(19)
(11) EP 1 254 102 A1

(12)

(43) Date of publication:
06.11.2002 Bulletin 2002/45

(21) Application number: 01946845.3

(22) Date of filing: 26.01.2001
(51) International Patent Classification (IPC)7C07C 69/734, A61K 31/216, C07C 59/64, A61K 31/192, A61P 3/04, A61P 3/06, A61P 3/10
(86) International application number:
PCT/DK0100/057
(87) International publication number:
WO 0105/5086 (02.08.2001 Gazette 2001/31)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 28.01.2000 DK 200000137
07.07.2000 DK 200001065
25.10.2000 DK 200001593

(71) Applicant: Novo Nordisk A/S
2880 Bagsvaerd (DK)

(72) Inventors:
  • MOGENSEN, John, Patrick
    DK-2730 Herlev (DK)
  • SAUERBERG, Per
    DK-3520 Farum (DK)
  • BURY, Paul, Stanley
    Burnley, Lancashire BB114PA (GB)
  • JEPPESEN, Lone
    DK-2830 Virum (DK)
  • PETTERSSON, Ingrid
    DK-1864 Frederiksberg (DK)

(74) Representative: Madsen, Inger Margrethe Schelde et al
c/o Novo Nordisk A/S,Patent Department,Novo Allé
2880 Bagsvaerd
2880 Bagsvaerd (DK)

   


(54) ALKYNYLSUBSTITUTED PROPIONIC ACID DERIVATIVES AND THEIR USE AGAINST DIABETES AND OBESITY